VPC-70063
VPC-70063 is an inhibitor of c-Myc-MAX. VPC-70063 exhibits Myc-Max transcriptional activity inhibition of 106% with an IC50 of 8.9 μM and Myc-Max/UBE2C downstream pathway inhibition of 94%. VPC-70063 can be used for studies about anticancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
378.33
Molecular Formula
C16H12F6N2S
Notes
Research use only, not for human use.
Receptor
P2X3
CAS Number
13571-44-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
10575124 3 x 1.0μg DNA
4921511H03Rik CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Ask
View Details 
MBS6137605-01 0.1 mL
MGAT5 (GGNT5, Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase, GlcNAc-T V, Mannoside Acetylglucosaminyltransferase 5, N-acetylglucosaminyl-transferase V) APC
Ask
View Details 
MBS6137605-02 5x 0.1 mL
MGAT5 (GGNT5, Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase, GlcNAc-T V, Mannoside Acetylglucosaminyltransferase 5, N-acetylglucosaminyl-transferase V) APC
Ask
View Details 